SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " mandate " 227 found 🔀 AI-powered Shuffle
New poll: Florida voters draw the line on school vaccine mandates
Voters overwhelmingly support keeping school vaccine requirements to protect children statewide.
Video Game Maker Ubisoft Unveils Major “Reset,” With Layoffs, Canceled Titles And Back-To-Office Mandate
Ubisoft, a major video game publisher known for titles like Assassin’s Creed, announced a major “reset” Wednesday involving layoffs, canceled and delayed games and a stricter return-to-office mandate. Co-founder and CEO Yves Guillemot said in a press release that the Paris-based company would “selectively close several studios and continue restructurings throughout the group. While these […]
Patriots' Robert Kraft lays out NFL's mandate to get bigger, richer: 18 games, international play for all 32 teams
Public health experts hold Q&A on vaccine science in Boston
On Tuesday, a panel of public health experts answered questions from the concerned public about vaccine science amid recent federal changes in vaccine mandates.
Public health experts hold Q&A on vaccine science in Boston
On Tuesday, a panel of public health experts answered questions from the concerned public about vaccine science amid recent federal changes in vaccine mandates.
Michigan Department of Education calls for stricter science of reading mandate
The Michigan Department of Education called for districts to be required to use literacy programs from a state-approved list.
Remote work persists despite Fortune 100's tighter office mandates
Remote work endures despite stricter RTO policies at Fortune 100 companies, as managers give the nod for more flexible arrangements.
Prof. Dorit Reiss Wins National Award for Distinguished Service in Health Law - UC Law San Francisco (Formerly UC Hastings)
Professor Dorit Reiss, who brings legal expertise to public health debates, has received a national award for her lasting contributions to the field as a scholar, policy adviser, and mentor. Faculty Who Lead: Dorit Reiss Professor Dorit Reiss receives the 2026 Distinguished Service Award from the AALS Section on Law, Medicine and Health Care. She is a leading expert on vaccine law, advising policymakers and providing expert analysis to journalists. Reiss mentors future health law scholars and combats misinformation online through evidence-based public education. Professor Dorit Reiss, a leading voice on vaccine law and policy, has won a national award recognizing her contributions to health law. She received the 2026 Distinguished Service Award from the Association of American Law Schools (AALS) Section on Law, Medicine and Health Care. Presented at the AALS Annual Meeting in January, the award honors sustained service to public health and the health law academy through advocacy, public education, and mentorship. In presenting the award, Professor Doron Dorfman of Seton Hall Law School, chair-elect of the AALS Section on Law, Medicine and Health Care, described Reiss as “a committed public health advocate who has used her expertise to influence vaccine policy, research, and practice at both the state and federal levels for nearly two decades.” Reiss leads a widely read vaccine law listserv that provides real-time updates on litigation, regulatory developments, advisory committee proceedings, and public comment opportunities. The resource has become an important tool for lawyers, scholars, journalists, and public health professionals tracking fast-moving developments in vaccine policy. Her service extends to policymaking as well. She has supported vaccine-related legislation in California, testified before the U.S. Senate Judiciary Committee on vaccine mandates and non-medical exemptions, and serves on the Parent Advisory Board of Voices for Vaccines, a parent-led organization focused on reducing vaccine-preventable disease. Dorfman also highlighted Reiss’ active role in robust debates over vaccine safety and related laws and policies. “She directly engages misinformation by responding to anti-vaccination claims on social media with careful, evidence-based rebuttals,” Dorfman said. As federal vaccine policy undergoes significant change, Reiss has become a trusted source for major national news outlets, including The New York Times, The Washington Post, and CNN, which regularly seek her expert analysis on new policies and decisions. Dorfman noted that Reiss is widely respected for her mentorship of health law faculty and scholars. “She is consistently generous with her time—approachable, willing to provide feedback, and a mentor to many in the field, including myself,” he said. At UC Law SF, Reiss brings the spirit of public service into the classroom, helping students understand how legal frameworks translate into real-world public health outcomes. She holds the James Edgar Hervey ’50 Chair of Litigation, a position that recognizes faculty excellence in the field of litigation. The Distinguished Service Award highlights her sustained commitment to evidence-based vaccine policy, public education, and mentorship during a pivotal time for public health law.
Flu prompts mask mandate at health system with Lancaster County operations
Starting today, masking is mandated for staff working in all Penn Medicine Lancaster General Health facilities who interact with patients.
NY touts new mandates for health insurers. Here's what they must cover
New York laws that took effect Jan. 1 require health insurers to cover breast cancer screening, EpiPens and scalp cooling for chemotherapy patients.
Banner Health to enforce mandatory masking starting Jan. 1 due to flu surge
A major Arizona hospital system is set to mandate masking at all locations in the Valley and five other states due to rising flu cases.
7 of the Biggest Moments in Public Health in 2025
The year 2025 was one of the most tumultuous ever for the healthcare industry. From the start of the second Trump administration on Jan. 20, change ensued immediately. From reconsiderations of vaccine mandates to overhauls in the makeup of a critical advisory panel to alterations of policy, public ...
Kosovo prime minister wins snap election to end political deadlock
Albin Kurti’s emphatic victory strengthens mandate for domestic reforms including welfare expansion
Democracy is under attack, right here in Colorado
Remember during COVID, when the people screaming the loudest for government-mandated jabs were the very same people chanting “my body, my choice” when it came to abortion — I mean, “women’s health care”? They’re also the folks who insist a 12-year-old is far too young to get a tattoo, but perfectly mature enough to make […]
New York to require social media platforms to display mental health labels
A new state law mandates warnings for young users on platforms with features that 'encourage excessive use'.
Justice Department’s heavy-handed redactions leave no one happy in the ‘Epstein files’ saga
The Justice Department’s release of the Epstein files — mandated by Congress to be completed last week — is still a work in progress.
New York parents say kids 'freeze' on mandated electric school buses during brutal winter weather
Parents in western New York report heating problems with mandated electric school buses, claiming children come home cold after rides in freezing weather.
Florida House advances proposal to mandate E-Verify
Only companies with 25 or more employees are required to use the system under current state law.
The fact-checking mandate evolves from politics to personal security
"Online scams, phishing attempts, and fraudulent schemes have grown in both volume and sophistication, creating a new front in the war on falsehoods."
The New WHO Pandemic Treaty and Global Health Governance: Incorporating Common but Differentiated Responsibilities into PABS - Georgetown Journal of International Affairs
On May 20, 2025, the World Health Assembly unanimously adopted the World Health Organization (WHO) Pandemic Agreement, an international treaty designed to strengthen pandemic prevention, preparedness, and response. The product of three years of arduous negotiations, the treaty marks a new era of global cooperation in public health. However, core aspects of the agreement remain unresolved—notably the Pathogen Access and Benefit-Sharing (PABS) System, which is intended to ensure equitable access to pandemic-related materials and benefits. To support the successful implementation of the WHO Pandemic Agreement, the principle of “common but differentiated responsibilities” should be formally incorporated into the negotiating agenda of the PABS annex. Introduction For the first time, an international treaty has enshrined the principle of “One Health,” the compelling idea that the health of animals, humans, and the environment all contribute to pandemic risks. SARS (2003), H1N1 (2009–10), Ebola (2014–16), and COVID-19 all emerged through zoonotic spillover from animal hosts—respectively, civets, hogs, and bats. Together, they underscore the need for a coordinated, cross-sectoral approach. The Pandemic Agreement responds to this call, requiring state parties to acknowledge the ecological interplay and commit to a comprehensive “One Health” strategy. Specifically, Article 5 charges governments to address “the drivers of pandemics and the emergence and re-emergence of infectious disease at the human-animal-environment interface,” including wild animal markets, deforestation, and antibiotic overuse. Yet the effectiveness of this “One Health” vision depends equally on the free flow of scientific information and data among countries and institutions. Just as environmental and animal health factors have been neglected in past global frameworks, so too has data sharing been marginalized, despite its centrality to timely detection and response. The Pandemic Agreement takes an important step by requiring governments to enhance data collection and cooperate with the World Health Organization (WHO). However, these provisions will remain aspirational without a robust Pathogen Access and Benefit-Sharing (PABS) annex. The PABS system will determine whether countries and researchers can rapidly exchange pathogen samples and genetic data while ensuring equitable access to resulting research and development, including diagnostics, therapeutics, and vaccines. Without such mechanisms, the treaty’s promise to operationalize “One Health” and strengthen global preparedness will risk becoming largely symbolic, echoing earlier failures to translate shared principles into coordinated action. Equity Concerns When the 2025 Health Assembly adopted the Pandemic Agreement, it left the difficult question of access to pathogens and the sharing of resulting benefits to be addressed in a separate agreement. Negotiations on this separate agreement, PABS, are now underway in Geneva. Yet governments remain divided over fundamental questions of equity between the countries that primarily contribute to the system and those that primarily draw from it—and consequently benefit. For example, wildlife in countries bordering the equator is likely to produce PABS materials, but companies in Europe are likely to use them to develop lucrative products. The most likely contributor countries are likely to be those biodiverse countries around the equator, such as Brazil, the Democratic Republic of the Congo, and Indonesia, where the number of human-mammalian viral host interactions is large. Conversely, countries most likely to benefit from this material are those with the technology, investors, and infrastructure to capitalize on genomic data, such as the United States, EU member states, and Japan. This imbalance reflects a broader pattern seen in prior international frameworks. Now, as in the past, the wealthiest countries in the world (a useful heuristic is membership of the Organisation for Economic Co-operation and Development (OECD)) disproportionately benefit from systems in which pathogens and genomic sequencing data are contributed to a common source. Under the International Agreement on Plant Genetic Resources for Food and Agriculture (the “Plant Treaty” or “Seed Treaty”) and the Pandemic Influenza Preparedness (PIP) Framework, companies from Europe and North America disproportionately withdraw biological samples and data for development into lucrative medical products. Their governments and companies have both statutory and contractual claims to the products that those companies correspondingly produce. PABS appears poised to follow the same pattern. The text calls for strong language on access to pathogens and associated data, but the corresponding benefits that should flow to poorer countries are couched in equivocal or non-binding language. Common but Differentiated Responsibilities To address these inequities, the principle of “common but differentiated responsibilities” should be formally incorporated into the negotiating agenda of the PABS annex. Common but differentiated responsibilities are often a feature of climate change negotiations. The basic principle is that, even though all countries should reduce carbon emissions, governments that became rich and powerful through massive carbon emissions (e.g., France, the United Kingdom, the United States) should have a greater obligation to address the resulting crises. Applied to PABS, it would require that governments hosting and supporting companies developing lucrative products carry greater obligations toward the cost of running the PABS system; share benefits or final medical products; and transfer technology to help countries worldwide develop their own capacities to innovate and manufacture vaccines during an emergency. For example, an annex could mandate that any company based in an OECD country that withdraws PABS material would be obligated to donate the resulting diagnostics, therapeutics, or vaccines to the WHO during a public health emergency or pandemic. Questions remain about how robust those donations would be, but the principle is that they should deliver highly significant lifesaving benefits to be equitably shared. Theoretically, this approach mirrors the PIP Framework, in which companies withdrawing influenza samples are required to pay half of the operating costs. In practice, however, the framework has fallen short. The PIP Framework Secretariat has struggled to secure payments from companies, with companies often disagreeing over how much is owed. Additionally, without another pandemic influenza to test the strength of the agreement during a public health emergency, corporate compliance with sharing mechanisms remains unknown. Even if these limitations did not characterize the PIP Framework, partially paying for operating expenses does not address the inequity in access to genetic data and pathogen samples that left less developed countries last in line for COVID-19 vaccines (and, before them, H1N1). Common but differentiated responsibilities would go further, addressing governments’ legitimate grievances regarding information sharing. It would make withdrawals of PABS material and resulting products more transparent, building trust across the board. Enforcement and Enduring Success A key implication of this approach is that the governing mechanism of the PABS must have real enforcement authority. The WHO Pandemic Agreement delegates its core governance responsibilities to a Conference of the Parties (COP)—a governing body composed of one representative from each participating government, similar to those established under the UN Framework Convention on Climate Change and the WHO Framework Convention on Tobacco Control. The proposed WHO Pandemic Agreement COP is charged with oversight functions but ultimately possesses no real authority to compel a government to take any action it does not wish to take. The text does not give the COP the ability to, for example, sanction a party that does not comply with either textual obligations or PABS provisions. In other words, there are no effective mechanisms in place to ensure compliance. Perhaps just as significant, establishing a meaningful enforcement mechanism within the PABS system would strengthen the WHO’s credibility and its ability to ensure compliance across global health governance. By setting a precedent for accountability, such a mechanism could enhance the organization’s authority not only within the Pandemic Agreement but also in enforcing the revised International Health Regulations and other frameworks for public health emergencies. Conclusion The PABS annex can—and should—be different. It should establish clear responsibilities for funding as well as for sharing the diagnostics, therapeutics, and vaccines that result from contributions to the system. The system, in turn, must include a dedicated body empowered to hold governments and the corporations they sponsor accountable for their responsibilities before, during, and after pandemics. Doing so would restore trust in the broader agreement, which was eroded as commitments were repeatedly diluted while parties scrambled to meet their own self-imposed deadlines during the Pandemic Agreement negotiations. A robust PABS Annex would cement a grand social bargain. Wealthier countries and their corporations would gain unimpeded access to scientific information essential for developing and manufacturing lifesaving medical products. As such, they would stand to gain considerable economic benefit. Yet that privilege must be matched with responsibility. The grand bargain must include not only the right to innovate, but also the duty to ensure that innovation serves all. As medical products are developed and produced through collective contributions, every person must have equal access. All human beings deserve an equitable chance to survive—to save their own life, the lives of their families, and the well-being of their communities. … Sam Halabi, JD, MPhil, is the Bette Jacobs Endowed Professor at Georgetown University’s School of Health and the Director of the Center for Transformational Health Law at Georgetown Law. He serves as the co-lead for the WHO’s Working Group on Regulatory Consideration on AI and Health’s training workstream. He earned his JD from Harvard, his MPhil from Oxford, and undergraduate degrees from Kansas State University. Lawrence Gostin, LLD (Hon.), JD, BA, is University Distinguished Professor and Founding Director and Timothy and Linda O’Neill Professor of the O’Neill Institute for National and Global Health Law. He is the author of Global Health Security: A Blueprint for the Future (Harvard University Press, 2021); Global Health Law (Harvard University Press, 2014); Public Health Law: Power, Duty, Restraint (University of California Press, 3rd ed., 2016); Public Health Law and Ethics: A Reader (University of California Press, 3rd ed., 2018); Law and the Health System (Foundation Press, 2014); Principles of Mental Health Law & Practice (Oxford University Press, 2010). He also directs the WHO Collaborating Center at Georgetown University. Image Credit: United States Mission Geneva, CC BY 2.0, via Wikimedia Commons
Scott: Sex-health ed changes have no basis in Elliott-Larsen Act
ELCRA protects against discrimination. It does not mandate curriculum.
I joined a company with an AI mandate. I was daunted at first, but I've saved hours by solving a big, boring problem.
When Komal Amin got a job at a company with an established AI mandate, she felt intimidated. Now, she uses it for everything from sending invoices to planning dates.
House bill aimed to counter N.Y. all-electric buildings mandate moves forward
The Energy Choice Act passed the U.S. House Energy and Commerce Committee on Wednesday.
DOGE is done. What did the agency accomplish?
As DOGE dissolves, questions remain about how close the agency came to fulfilling President Donald Trump's mandate.
Funders "should mandate change in science publishing"
Paper argues that funders, governments and universities should intervene more forcefully to prevent "draining of research"
Why Your Company Needs a Chief Data, Analytics, and AI Officer
Who should be in charge of data, analytics, and AI? While there are many possible divisions of responsibility and reporting structures, a combined role—the CDAIO (Chief Data, Analytics, and AI Officer)—will best prepare organizations as they plan for AI going forward. To succeed, this role needs a clear mandate that includes owning AI strategy, preparing for a new class of risks, developing the AI tech stack, ensuring the company’s data is ready for AI, creating an AI ready culture, developing talent and partnerships, and generating significant ROI on AI investments. Given the emphasis on business value creation, in most cases CDAIOs should be positioned closer to business functions than to technology operations.
2026's hottest real estate markets are reaping the benefits of RTO
Real estate experts said in a survey that the Northeast is area to watch for real estate in 2026, largely thanks to return to office mandates.